How medicines are funded
PHARMAC has an established process for deciding which medicines to fund. We consider Pharmaceutical Schedule funding applications from pharmaceutical suppliers, health professionals, consumer groups and patients.
Process for listing a new pharmaceutical
The process set out in this diagram is intended to be indicative of the process that may follow where a supplier or other applicant wishes a pharmaceutical to be funded on the Pharmaceutical Schedule. PHARMAC may, at its discretion, adopt a different process or variations of the process (for example, decisions on whether or not it is appropriate to undertake consultation are made on a case-by-case basis).
Note that implementation of a decision includes both positive and negative funding decisions. These may include notification of a Schedule listing or listing that an application has been declined.
Last updated: 29 March 2016